bjr-83-493 Tir

Europe PMC Funders Group
Author Manuscript
Lancet Neurol. Author manuscript; available in PMC 2019 September 10.
Published in final edited form as:
Lancet Neurol. 2016 April 01; 15(4): 420–433. doi:10.1016/S1474-4422(15)00383-X.
Europe PMC Funders Author Manuscripts
Brain imaging in the assessment for epilepsy surgery

Prof John S Duncan, FRCP,
Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology; University College
London, London, UK; National Hospital for Neurology and Neurosurgery, London, UK; Chalfont
Centre for Epilepsy, Chalfont St Peter, Gerrards Cross, UK
Gavin P Winston, PhD,

Prof Matthias J Koepp, PhD,

Prof Sebastien Ourselin, PhD

Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology; Translational
Imaging Group, Centre for Medical Image Computing; University College London, London, UK;
National Hospital for Neurology and Neurosurgery, London, UK
Abstract
Brain imaging has a crucial role in the presurgical assessment of patients with epilepsy. Structural
imaging reveals most cerebral lesions underlying focal epilepsy. Advances in MRI acquisitions
including diffusion-weighted imaging, post-acquisition image processing techniques, and
quantification of imaging data are increasing the accuracy of lesion detection. Functional MRI can
be used to identify areas of the cortex that are essential for language, motor function, and memory,
and tractography can reveal white matter tracts that are vital for these functions, thus reducing the
risk of epilepsy surgery causing new morbidities. PET, SPECT, simultaneous EEG and functional
MRI, and electrical and magnetic source imaging can be used to infer the localisation of epileptic
foci and assist in the design of intracranial EEG recording strategies. Progress in semi-automated
methods to register imaging data into a common space is enabling the creation of multimodal
three-dimensional patient-specific datasets. These techniques show promise for the demonstration
Correspondence to: Prof John S Duncan, Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London,
WC1N 3BG, UK, [email protected].
Contributors
JSD, GPW, MJK, and SO did the literature searches, interpretation, writing, and editing of this Review.
Declaration of interests
JSD has received personal fees from Eisai and non-financial support from Medtronic and has a patent pending for computer-assisted
planning for neurosurgery. MJK has received personal fees from General Electric for PET tracer development, and from UCB, BIAL,
and Eisai for antiepileptic drug development. SO has received grants from General Electric, Siemens, IXICO, MIRADA Medical, and
IcoMetrix, and has a patent pending for computer-assisted planning for neurosurgery. GPW declares no competing interests.
Duncan et al. Page 2
of the complex relations between normal and abnormal structural and functional data and could be
used to direct precise intracranial navigation and surgery for individual patients.
Introduction
Epilepsy develops in 50 in every 100 000 people per year; in a third of these people,
antiepileptic drugs do not control seizures.1 About half of these latter individuals have focal
epilepsy that is potentially amenable to neurosurgical treatment if there is evidence to
suggest a single focal network underlying the epilepsy, if the individual would be able to
withstand neurosurgery,2 and if they do not have severe comorbidities, such as active cancer,
advanced vascular disease, or dementia.
Brain imaging is of fundamental importance to diagnosis and treatment of epilepsy,

particularly when neurosurgical treatment is being considered. Dramatic advances have been
made in brain imaging applied to epilepsy in the past 20 years, principally because of
advances in MRI scanner technology, acquisition protocols, and image processing methods,
and in nuclear medicine.3 In this Review, we focus principally on advances made since 2005
that are of potential clinical importance to the practising neurologist. We first review
developments in structural brain imaging with MRI and post-acquisition processing methods
to identify cerebral abnormalities that might cause epilepsy, the identification of which
might lead to consideration of surgery. We then describe the mapping of areas of cortex that
are essential for language, motor, and memory functions (eloquent cortex) and the crucial
white matter pathways in the brain. Next, we review PET and other imaging methods to
infer the localisation of cerebral networks that could generate epileptic seizures in the
context of MRI findings that are inconclusive or discordant with clinical and EEG data.
Finally, we review the integration of multimodal three-dimensional imaging data and how
these methods have an evolving role in the design of treatment strategies for individual
patients, and consider forthcoming advances. Panel 1 comprises a glossary of MRI terms
used in this Review.
In the interpretation of imaging studies, an important factor is recognition of the difference

between group studies, as used in neuroscience investigations to infer the functional
anatomy of the brain and its abnormalities in a disorder, and clinical studies, in which the
results affect the diagnostic and treatment pathways of individual patients. The latter are
focused on individuals with medically refractory focal epilepsies, and their surgical
treatment, in whom the finding of focal abnormalities might lead to a surgical solution and
identification of critical structures might constrain the surgical approach.
The sequence of presurgical imaging investigations

The prerequisite for imaging investigations in the presurgical assessment of patients with
epilepsy is high-quality structural MRI, interpreted in the context of clinical and EEG data,
with quantification of hippocampal volumes and T2 signal, to identify an epileptogenic
lesion. If there is a relevant structural lesion that is concordant with the results of scalp video
EEG telemetry and not close to eloquent cortex, the patient can be recommended for
surgery, with functional MRI (fMRI) at this time to assess language lateralisation. If a

resection is planned that is close to the optic radiation or corticospinal tract, diffusion
imaging and tractography to help to optimise the surgical approach and minimise the risks of
surgery is recommended. Figure 1 shows the place of imaging studies in the presurgical
pathway.4
If an individual has no relevant lesion on MRI, further acquisitions using the latest MRI
hardware and techniques and post-acquisition processing methods might reveal a subtle
abnormality, but findings should be interpreted with caution owing to the possibility of false-
positive results. 18F-fluorodeoxyglucose (18F-FDG) PET is a useful next step because it can
be used to identify a single area of hypometabolism that might lead directly to resection—
eg, if there is reduced uptake in the anterior temporal lobe in the non-language dominant
hemisphere—or, more commonly, to inform an intracranial EEG recording. If abnormalities
are not identified on 18F-FDG PET imaging, subsequent investigations are geared towards
generation of a hypothesis regarding the location of the epileptogenic zone that can be tested
with intracranial EEG. These investigations include ictal SPECT and visualisation of
interictal, and rarely ictal, epileptic activity with electrical source imaging (ESI), magnetic
source imaging (MSI), and simultaneous EEG and fMRI (EEG-fMRI). In practical terms,
the hierarchy of these investigations will depend on their availability in individual centres.
Three-dimensional multimodal imaging has an evolving role in the integration of structural
and functional data for the planning of invasive EEG studies and resections.
Identification of structural cerebral abnormalities

Structural MRI is the main neuroimaging technique for identification of an epileptogenic
lesion. Localising and delineating the extent of the underlying lesion and its relation to
eloquent cortex forms a crucial part of the assessment for surgery. Identification of a lesion
leads to a greater chance of seizure freedom after surgery.5,6 However, 15–30% of patients
with refractory focal epilepsy do not have distinct lesions on MRI (ie, they are MRI
negative).7,8 The underlying pathological abnormalities, the acquisition protocol, and the
interpretation, by human or computational analysis, are key determinants in the
identification of structural abnormalities.
Acquisition protocol
Acquiring images using an optimised epilepsy protocol maximises the potential to identify
structural abnormalities. The basic protocol established by the International League Against
Epilepsy9 includes whole-brain T1-weighted and T2-weighted imaging acquired with the
minimum slice thickness possible in two orthogonal planes and a volumetric T1-weighted
acquisition for three-dimensional reconstruction (figure 2). This guideline is 18 years old
and updated guidance that takes into consideration recent advances made in brain imaging
would now be appropriate.
Additional sequences, in particular fluid-attenuated inversion recovery (FLAIR) MRI, have

become available, and scanner hardware has improved (figure 2).10 Analysis of MRI data
showing epileptogenic lesions in 2740 surgical patients in Bonn, Germany, led to a proposal
for a specific MRI protocol (panel 2)11 that is advantageous from both a sensitivity and
economic point of view and is now widely accepted.12

Imaging hardware
Imaging hardware has improved, with increased field strength and better coils and gradients.
An increased field strength improves signal-to-noise ratio and enables greater spatial
resolution. Rescanning surgical candidates who were MRI negative on a 1·5 T scanner using
a 3 T scanner with phased-array coil MRI enabled identification of a lesion in 15 of 23
patients.13 A retrospective review of 804 unselected patients who had MRI at 1·5 T and
subsequently at 3 T showed relevant new diagnoses in 37 (5%), in particular hippocampal

sclerosis, focal cortical dysplasia, and dysembryoplastic neuroepithelial tumour.14 7 T
imaging is anticipated to reveal further anatomical detail, including delineation of
hippocampal subfields15,16 and increased identification of abnormalities that are not evident
on conventional clinical MRI. However, higher field strength brings with it challenges,
including image distortion and artifacts, and issues with patient tolerance that can make
clinical interpretation and decisions on the relevance of findings difficult.
Scan interpretation
Even with optimum acquisition, scan interpretation is subject to the expertise of the
radiologist. In patients undergoing surgery, sensitivity in detection of focal epileptogenic
lesions was 39% from non-optimised imaging reported by non-experts, 50% when reported
by experts, and 91% when an optimised acquisition was used and reported by experts.17
Curvilinear reformatting of volumetric T1-weighted images improves the display of gyral
structure and helps to identify subtle abnormalities not seen on planar slices.18 The clear
message is that both acquisition using an epilepsy protocol and reporting by a skilled
neuroradiologist who has all the relevant clinical data increase greatly the identification of
relevant lesions that might underlie epilepsy.
Assessment of structural data

A substantial development in the past decade has been the automated quantitative
assessment of structural data, which can be applied to datasets from individuals.19 The most
commonly missed diagnoses in MRI-negative patients are hippocampal sclerosis and focal
cortical dysplasia.
Hippocampal sclerosis—Hippocampal sclerosis is the most common cause of surgically

remediable temporal lobe epilepsy and can be assessed with volumetry and T2 relaxometry.
Quantification of hippocampal changes is particularly important, and strongly
recommended, when considering epilepsy surgery, to detect subtle atrophy and signal
changes that might not be identified visually and to establish whether the contralateral
hippocampus is structurally normal. Bilateral hippocampal abnormalities raise concerns of a
reduced chance of seizure freedom after anterior temporal lobe resection and an increased
risk of memory impairment.20 Time-consuming manual volumetry can be replaced by
automated segmentation, which is available freely on the internet,21 and localised shape
changes can be detected even in patients who seem to be MRI negative.22 Voxel-based
approaches to T2 relaxometry might be more sensitive than traditional approaches based on
region of interest analyses.23

Computerised analysis of hippocampal FLAIR signal has been used to identify hippocampal
sclerosis with 97% sensitivity and 95% specificity,24 and a combination of hippocampal
volumetry and FLAIR signal measurements has been used to identify moderate and severe
hippocampal sclerosis.25 However, findings from a direct comparison between automated
FLAIR signal analysis and hippocampal T2 relaxometry suggested that T2 relaxometry was
more sensitive.26
Apart from manual hippocampal volumetry, the use of these techniques has largely remained
confined to the centres that developed them and a few collaborating centres. For wide
dissemination, validated methods need to be readily available, be quick and intuitive to use,
and have adequate technical support in place.
Focal cortical dysplasia—Cortical malformations, in particular focal cortical dysplasia,

underlie many paediatric and around a quarter of adult MRI-negative refractory epilepsies.27
Imaging findings include focal cortical thickening, blurring of the grey–white matter
junction, and high signal on T2-weighted or FLAIR images in underlying white matter.28
However, MRI is often normal, particularly in type I focal cortical dysplasia, and up to 80%
of focal cortical dysplasia lesions cannot be visually detected when located in the depths of a
sulcus.29 Advances in imaging acquisition protocols are likely to enable the detection of
previously unidentified abnormalities such as focal cortical dysplasia. For example, double-
inversion recovery suppresses signal from both CSF and white matter, improving contrast in
the cortex.30 Arterial spin labelling can be used to visualise tissue perfusion, and reduced
blood flow might co-localise with focal cortical dysplasia.31 Development in diffusion
imaging methods such as neurite orientation dispersion and density imaging or diffusional
kurtosis imaging, which provide more detail on tissue microstructure, increase sensitivity for
the detection of focal cortical dysplasia (figure 3).32
Voxel-based morphometry (VBM) was originally applied to T1-weighted images for the
quantitative analysis of grey and white matter distribution,33 initially for group comparisons,
but subsequently to compare an individual with a control population.19 Findings from an
initial study showed that 21 of 27 patients with focal cortical dysplasia were correctly
identified.34 Voxel-based analysis has been applied to T2 relaxometry maps35 and FLAIR
images to increase sensitivity for detection of focal cortical dysplasia36 and for detection of
abnormalities in those who are MRI negative.37 Improved detection of focal cortical
dysplasia has been achieved with a morphometric analysis procedure based on VBM
methods that produces a junction map to highlight blurring of the grey–white matter
boundary and an extension map to delineate abnormally deep sulci (figure 2G).10 In one
study, morphometric analysis complemented visual reading of MRI scans by an expert
neuroradiologist.38 As with many other image analysis instruments, there has not been
widespread uptake of these methods, which are often perceived by clinicians outside
specialist units as being complicated and non-intuitive.
Focal cortical dysplasia can be associated with abnormal gyral and sulcal patterns not
detected with VBM. Surface-based morphometry techniques generate geometric models of
the cortical surface that allow features such as cortical thickness to be measured. This
technique can be extended to analyse many morphological (cortical thickness, curvature, and

depth) and textural (blurring of grey–white matter interface and T1 hyperintensity) features
to enable the detection of focal cortical dysplasia.39 By combining many parameters with
machine learning techniques to classify lesional and non-lesional vertices, focal cortical
dysplasia was detected in 14 of 24 MRI-negative patients.40 An automated classifier based
on surface morphology and intensity gave 60% sensitivity to detect type II focal cortical
dysplasia (three of seven with type IIA and six of eight with type IIB) that was not evident
on visual reading, with no false-positive findings but with some extralesional clusters.41
Automated detection methods have a promising role in augmenting visual assessment,
particularly with focal cortical dysplasia type IIB.
Data interpretation for advanced imaging methods

An important caveat is that although advances in field strength, gradients, acquisitions, and
post-acquisition processing and quantification will result in increased identification of subtle
abnormalities that might underlie epilepsy, a detection rate of above 20–30% cannot be
expected in individuals with no clear abnormalities on conventional MRI scans.42
Undoubtedly, some patients with focal epilepsy (eg, those with a neurochemical
derangement) will not have a focal cerebral structural abnormality. In these patients,
functional imaging, including perfusion and nuclear medicine techniques, could be used to
infer the location of an epileptogenic network (see later). A further important caveat is that
more sensitive methods will inevitably produce some spurious findings, which might include
false-positive artifacts and true findings, such as increased T2 signal around the lateral
ventricle, that are not relevant to the epilepsy. It is important, therefore, to apply so-called
fuzzy logic by a sceptical expert to assessment of all imaging data and to interpret the
findings in the context of clinical and EEG information.
Mapping eloquent brain functions

Identifying the cerebral lateralisation of speech and the localisation of eloquent functions is
crucial when planning surgical resections close to areas of the brain involved in these
functions, so that the risk of creating new deficits can be taken into account when making a
decision about surgery and the surgical approach can be planned to minimise the risk.
Language
fMRI can be used to map language networks in patients with epilepsy for clinical and
research purposes. Various language tasks that activate anterior (ie, Broca’s area) and
posterior (ie, Wernicke’s area) language areas have been used to establish patterns of typical
and atypical language lateralisation.43 Verbal fluency, verb generation, and semantic
decision tasks are used commonly for assessment of language in a clinical context, providing
complementary information.44 In addition to visual reading of the numbers of activated
voxels, the lateralisation index of activation in preselected regions of frontal and temporal
lobes gives a quantitative measure of left–bilateral–right dominance that brings objectivity to
decisions relating to epilepsy surgery and is useful for research studies. Conventional and
adaptive thresholds and bootstrap techniques have been used; the latter has the advantage of
being more specific and able to identify outliers.45

Individuals with left hemisphere epilepsy are more likely to have atypical language
lateralisation than those with right hemisphere epilepsy.46 Individuals with left temporal
lobe epilepsy and left language dominance recruit homologous right hemisphere areas for
language processing, suggesting widespread language representation.47 Individuals with
temporal lobe epilepsy are more likely to have atypical language lateralisation in Wernicke’s
area, whereas anterior language areas are more affected in those with frontal lobe foci.48
Many factors combine to affect language laterality. Left handedness is associated with an
increased likelihood of a language shift to the right hemisphere in temporal lobe epilepsy, as
is a left-sided focus, onset of epilepsy at 12–20 years, and absence of a genetic
predisposition for left handedness.46,49 Increased grey matter volume in language networks
in the hemisphere contralateral to the epileptic focus suggests hard-wired compensatory
mechanisms of reorganisation.50
Language lateralisation inferred from fMRI findings concurs with findings from the
intracarotid amobarbital test (also known as the Wada test) in 80–90% of patients when
using conjunction analysis of three language tasks.51 Concordance between fMRI and
intracarotid amobarbital test findings is greatest for patients with right temporal lobe
epilepsy with left language dominance, and lowest for patients with left temporal lobe
epilepsy with left language dominance.52 The consensus in most epilepsy surgery centres is
that fMRI language lateralisation can replace the intracarotid amobarbital test in most
patients to establish hemispheric dominance. However, the latter might be needed when a
patient cannot perform the fMRI task, if fMRI is contraindicated, and, in some cases, for the
validation of atypical, inconclusive, or not clearly lateralised language activation on fMRI.53
Preoperative fMRI activation in response to a verbal fluency task in the middle and inferior
frontal gyri predicts substantial decline in verbal naming after left temporal lobe resection,
with good sensitivity but poor specificity.54 It is intuitive that a language activation task that
primarily activates the part of the temporal lobe that is to be removed in surgery will be a
better predictor of word-finding difficulties after temporal lobe resection than a task that
primarily activates the adjacent frontal lobe. Auditory and visual naming tasks have promise
in this regard and might enable more specific prediction of naming difficulties after anterior
temporal lobe resection.55
When a cortical resection is needed close to eloquent language cortex, the localisation
inferred from language fMRI is not adequate to guide resection because areas that do not
seem to be activated at the threshold used to display data might be necessary for language
function, and areas that are activated might not be crucial. As a consequence, electrocortical
stimulation or awake resections, or both, are necessary in such cases.56 Cortical language
function can also be localised with navigated transcranial magnetic stimulation and the
results mapped onto the individual’s MRI scan. However, concordance with the standard of
direct cortical stimulation was impaired in those with lesions.57 An active area of research is
assessment of whether non-invasive language mapping with fMRI or transcranial magnetic
stimulation might render direct cortical stimulation unnecessary.

Episodic memory
Memory impairment commonly accompanies temporal lobe epilepsy and a clinical concern
is the risk of temporal lobe surgery causing worsened memory. Verbal memory encoding
activates a bilateral network including temporal, parietal, and frontal lobes. Greater left
hippocampal activation for word encoding is correlated with better verbal memory in
patients with left temporal lobe epilepsy.58 Visual memory encoding recruits a more
widespread bilateral cortical network, and greater right hippocampal activation for face
encoding is correlated with better visual memory in patients with right temporal lobe
epilepsy.58 Functional reorganisation of networks involving extra-temporal and temporal
structures for verbal-specific and visual-specific memory encoding suggests that
compensatory mechanisms are in operation to mitigate the impaired function of the sclerotic
hippocampus.59,60
Verbal memory declines in a third of patients undergoing left temporal lobe resection and
visual memory declines in a third of those who have right temporal lobe resection.58,60,61
The ability to predict this decline is important to be able to advise individual patients of their
risks. Preoperative memory ability, age at onset of epilepsy, language lateralisation, and
asymmetry of activation on fMRI for verbal and visual memory can be predictive of verbal
memory decline after left anterior temporal lobe resection, but are less accurate predictors of
visual memory decline after right anterior temporal lobe resection.58,61 In a comparison of
seven fMRI protocols, a verbal memory task showed the most consistent activation and was
best able to discriminate between patients with left and right temporal lobe epilepsy,62
suggesting that fMRI assessment of verbal memory is useful for identifying abnormal
temporal lobe function.
In individuals with left temporal lobe epilepsy, predominantly left-sided anterior

hippocampal activation in response to a word encoding task was correlated with greater
decline of verbal memory after left anterior temporal lobe resection.58 Conversely,
predominantly left-sided posterior hippocampal activation was correlated with better verbal
memory after resection.58 In those with right temporal lobe epilepsy, predominantly right-
sided anterior hippocampal activation in response to face encoding was associated with
greater decline of visual memory after right anterior temporal lobe resection, and
predominantly right-sided posterior hippocampal activation was associated with superior
visual memory after surgery. Memory activation patterns before surgery were the strongest
predictor of verbal and visual memory loss as a result of anterior temporal lobe resection,
and preserved function in the ipsilateral posterior hippocampus seems to help to maintain
memory encoding after anterior temporal lobe resection.58 In another study, a clinically
applicable fMRI verbal memory task that was used to assess the lateralisation index of
memory and associated language functions in the medial temporal and frontal lobes was the
best predictor of verbal memory decline after temporal lobe resection (figure 4), compared
with language fMRI and clinical parameters.63 Replication of these findings is needed to
establish whether this method would be suitable for widespread use.

Motor function
fMRI with finger and foot tapping tasks can be used to identify the primary motor cortex,
which is beneficial when planning intracranial EEG implantations and resections. fMRI
generally gives results that are concordant with findings from cortical stimulation and high
gamma electrocorticography.64 In patients with frontal lobe epilepsy, activation is reduced
on the side of the focus after seizures. This finding implies that seizures affect motor
circuitry, but does not suggest that the location of the primary area of activation is affected.65
Navigated transcranial magnetic stimulation has been used to map activations with a mean
Euclidean separation from the direct site of invasive cortical stimulation of 11 mm (SD 4)
for the hand and 16 mm (SD 7) for arm muscle representation areas, with locations within
the same gyrus, thus giving an accuracy suitable for epilepsy surgical assessments.66
Resections close to motor cortex still need direct electrocortical stimulation mapping or for
resections to be done while the patient is awake, or both, to minimise the risk of causing a
lasting deficit.
Resting state and connectivity

Impaired brain function occurs not only if an eloquent area is damaged, but also if functional
connectivity within and between eloquent areas is affected. Cognitive impairment has been
reported in children with frontal lobe epilepsy in association with decreased functional
frontal lobe connectivity, despite having intact fMRI activation in response to a working
memory task, emphasising the effect of impaired functional networks on cognition.67 In
adults with temporal lobe epilepsy, resting-state thalamo-temporal functional connectivity
was associated with long-term memory performance, and thalamo-prefrontal functional
connectivity was associated with short-term memory performance.68 A machine-learning-
based analysis of resting-state functional connectivity has been proposed as a method to
establish lateralisation of the seizure focus in temporal lobe epilepsy.69 Impaired
connectivity in a network involving the anterior nucleus and pulvinar of the thalamus has
been reported in temporal lobe epilepsy.70 Although fMRI studies of functional connectivity
can be used to investigate the pathophysiology of epileptic networks, and hold promise for
assisting with the prediction of epilepsy surgery outcome, the potential benefit for clinical
studies of individual patients is not established.
Mapping cerebral white matter connections

fMRI can be used to identify eloquent cortex, but surgical damage to white matter
connections must also be avoided to prevent postoperative neurological deficits.
Tractography data derived from diffusion-weighted MRI, usually diffusion tensor imaging,
enables the non-invasive in-vivo delineation of white matter tracts.
Most clinical research into white matter tracts in patients with epilepsy has focused on the
optic radiation because damage to Meyer’s loop during anterior temporal lobe resection can
cause a visual field deficit that can preclude driving.71 The extent of resection and distance
from Meyer’s loop to the temporal pole on preoperative tractography are predictive of the
risk of a visual field deficit,72 and tractography therefore can be used to assist with surgical
planning and risk stratification.73 Display of tractography data during surgery with

correction for brain shift using intraoperative MRI reduces the risk of a visual field deficit
(figure 5).74,75
Delineation of the corticospinal tract in patients undergoing frontal lobe surgery is

beneficial, particularly in children for whom fMRI is challenging. Localisation inferred by
tractography gives similar results to invasive electrical stimulation mapping and can be used
to predict the risk of postoperative motor deficits.76 Much work on the corticospinal tract has
been done in patients with gliomas, which can readily be translated to patients with epilepsy.
More limited data are available on the arcuate fasciculus, which might be a result of a
weaker association between damage and postoperative outcomes arising from the
multiplicity of language pathways. Nevertheless, tractography might have a role in the
assessment of paediatric patients for epilepsy surgery.77 Moreover, tractography of all three
tracts with intra-operative MRI was beneficial in reducing the risk of deficits after
ganglioglioma surgery in adults.78
However, tractography has limitations. The tracts obtained are assumed to be a faithful
representation of the underlying anatomy, but spatial resolution and modelling limitations
result in inaccuracy. Different algorithms give varying results.79 Data derived from
diffusion-weighted images are distorted compared with anatomical scans, and their use
during surgery ideally involves correction for brain shift with intraoperative MRI. Although
intraoperative MRI is helpful, cost and availability are restrictive. Future developments
should include better diffusion models, automation of tractography, its use with standard
neuronavigation systems, and correction for brain shift using alternative techniques such as
ultrasound.
Localisation of epileptic activity

If MRI does not show a structural lesion that is concordant with clinical and EEG data,
further investigations are necessary to infer the localisation of the epileptic network (figure
1).4
PET imaging
PET imaging is an important investigation for non-invasively localising epileptogenic brain
regions in MRI-negative focal epilepsies, in patients with more than one abnormality, or if
MRI and ictal EEG are not concordant.
18F-FDG PET has been used for epilepsy surgery assessments since before the advent of
MRI. The wide availability of the method in oncology centres, and its use as an interictal
investigation, results in 18F-FDG PET generally being used in preference to ictal SPECT
(see later) in the epilepsy surgery pathway.
Regional cerebral hypometabolism identified with 18F-FDG PET often has a wider
distribution than that of the seizure focus, which can represent both the focus and projection
areas of seizure activity (figure 6).80 This absence of specificity makes surgical decisions on
the extent of resective surgery difficult. However, in a study of post-operative outcomes,

patients who were seizure free after surgery had more of the hypometabolic area resected
than did individuals who continued to experience seizures.81
The main advantage of clinical PET imaging for its future use is that it is versatile, allowing
not only mapping of in-vivo processes, such as perfusion and metabolism, but also the
quantification of the distribution of radiolabelled markers with concentrations in the
nanomolar range. This versatility depends on the availability of a cyclotron and

radiochemistry laboratory. For tracers labelled with 11C, which has a half-life of 20 min, the
cyclotron and radiopharmacy laboratory has to be in the same location as the scanner, which
greatly reduces the applicability outside a few centres. 18F has a half-life of 2 h, so
production can be at a distant facility and the tracer shipped to the scanner.
Several PET receptor ligands have been used to assess neurotransmitter systems involved in
the pathophysiology of epilepsy. 11C-flumazenil PET imaging can be used to detect
reductions in GABAA receptor binding, but with limited success in localisation of epileptic
foci in patients with normal MRI.82 In a group of patients with difficult-to-treat focal
epilepsies, reduced 11C-flumazenil binding was found in the temporal piriform cortex, which
was associated with increased seizure frequency.83 This finding raised the possibility of the
existence of a common network and that removal of the temporal piriform cortex might be
relevant for achieving postoperative seizure freedom.83 18F-flumazenil is, in some centres,
more widely available than 11C-flumazenil and thus might be more useful in understanding
the clinical benefit of benzo-diazepine receptor imaging.84
α-11C-methyl-L-tryptophan was considered originally to be a marker of serotonin synthesis,

but uptake of this tracer in PET imaging is now thought to be an indicator of altered
excitatory aminoacid concentrations and inflammatory pathways. An increased uptake can
be used to reliably identify an epileptogenic tuber in patients with tuberous sclerosis when
more than one tuber is present.85 If replicated, this imaging method could be very useful in
this context and in the identification of abnormalities in individuals with normal MRI.
SPECT imaging
SPECT imaging can provide information about dynamic changes in cerebral perfusion
before, during, and after a seizure. Timing of injection and duration of the seizure are
important for correct interpretation of the SPECT images, because delayed injection can
result in a variable pattern of blood flow changes as the seizure evolves and propagates. True
ictal SPECT shows an area of hyperperfusion in the epileptogenic region, surrounded by an
area of hypo-perfusion that might be caused by shifting of blood flow to the seizure focus or
might represent an inhibitory zone that limits the seizure spread.86 Limitations of ictal
SPECT include the complex logistics needed, the fact that only one dataset representing
cerebral blood flow is obtained, and timing issues. After intravenous injection, the tracer
takes at least 40 s to reach the brain, cross the blood–brain barrier, and become fixed. Thus,
with a short seizure of less than 30 s, the image of cerebral blood flow will inevitably be
post-ictal rather than ictal, and even with a longer seizure, areas of propagation rather than
onset will be visualised. Ictal SPECT in the presurgical assessment pathway is most useful
in patients with refractory focal epilepsy who have MRI that is normal or discordant with
clinical and EEG data, and to assist with formulation of a hypothesis of seizure onset

localisation that can be tested with intracranial EEG. Ictal SPECT imaging would not
usually be used to directly support a resection.
EEG-fMRI, ESI, and MSI

Simultaneous scalp EEG-fMRI recordings can be used to map haemodynamic changes
associated with interictal epileptic discharges with 30–40% sensitivity87 and might be useful
for planning intracranial implantations,88 with widespread abnormalities taken as a warning

sign of poor outcome from resection.89 If an individual has frequent seizures, an ictal EEG-
fMRI recording can be obtained. Focal or widespread haemodynamic changes are often seen
before the onset of seizures on scalp EEG recordings, suggesting that additional brain
networks might be involved before seizure onset on scalp EEG,90 and highlighting the low
sensitivity of scalp EEG.91 In generalised epilepsies, EEG-fMRI has shown involvement of
cortico-subcortical networks during generalised spike wave discharges.92 The clinical role of
scalp EEG-fMRI is that localisation of identified ictal and interictal networks can be useful
during presurgical assessment, helping with the design of intracranial EEG sampling
strategies and showing whether there is likely to be a poor outcome, which may dissuade the
clinician from proceeding.
Simultaneous recording of intracranial EEG and fMRI is possible93 and can show
haemodynamic alterations occurring before the first detected EEG changes, suggesting the
presence of a distributed network and that the implanted electrodes are at a distance from the
site of epileptic activity.94
ESI, based on reconstruction of electrical activity derived from high-density scalp EEGs, can
produce more prolonged recordings than is possible with EEG-fMRI or MEG and can be
used to identify the irritative zone generating interictal epileptic activity. A large number of
channels (eg, 128) are needed for high-quality ESI. The results need to be computed with the
individual’s MRI data. Inaccurate modelling of electromagnetic field propagation can result
in errors. Comparison with subsequent intracranial EEGs has shown a median separation of
13–16 mm between the ESI and the intracranial contact showing maximum discharges.95
Resection of the interictal ESI maximum has been associated with a good surgical outcome,
96 and the concordance of an ESI focus with an MRI lesion has been associated with a 92%
chance of good seizure outcome after resection.97 If replicated, these findings suggest a role
for ESI early in the epilepsy surgery pathway, with the possibility of other investigations
becoming redundant.
MSI, based on a combination of magnetoencephalography (MEG) and MRI data, when used
to map interictal epileptic activity, seems promising in retrospective studies, with higher
seizure freedom rates if a computed dipole was concordant with other data than if dipoles
were discordant or non-specific.98,99 Electrical and magnetic source localisation are
complementary and their combination improves the accuracy of source localisation and
identification of propagated activity.100
In practical terms, EEG-fMRI, ESI, and MSI are used to map interictal epileptic activity,
with a small chance of including ictal activity, the possibility being greater with ESI because
more prolonged recordings are feasible. The roles of these techniques in the presurgical

algorithm have not yet been established. For individuals with concordant MRI and ictal and
interictal video EEG findings, further data are redundant. The patients who stand to benefit
are those for whom there is not a clear surgical solution and who would need intracranial
EEG to define the epileptogenic zone. Data from additional techniques can help to generate
a hypothesis that can be tested with intracranial EEG and to identify patients in whom
abnormalities are widespread and in whom invasive studies should not be done. Prospective
studies to assess the role of these techniques in the presurgical algorithm will be challenging
because the three techniques are not likely to be developed to a similar level in any one
centre, and a multicentre study with at least 12 months of postoperative follow-up would be
needed. Each method would probably show some usefulness, with all three contributing to
localisation of seizure source in some cases, and any one technique being uniquely helpful in
a subset of patients.
Integration of multimodal three-dimensional imaging in the epilepsy

surgery pathway
In 20–30% of candidates for epilepsy surgery, intracranial EEG is needed to define the
epileptogenic zone.101 Increasingly, this is accomplished with stereotactic placement of
several (ie, 12–20) depth electrodes (stereo-electroencephalography; SEEG). SEEG
electrodes can be used to record from a 1 cm core around the cerebral entry point to the
distal end (ie, target), which can be placed in the hippocampus, amygdala, or midline or
inferior neocortex. Electrode implantation carries a risk of haemorrhage, neurological
deficit, and infection.102 Preoperative planning of electrode trajectories using multimodal
imaging, defining deep and superficial targets and skull entry points, can minimise
implantation risk by ensuring that the electrodes avoid critical structures, particularly arteries
and veins, and contact with other electrodes. Precise planning can also improve the
efficiency of the recording by ensuring that electrode contacts sample grey rather than white
matter. At present, standard clinical practice for planning electrode trajectories involves
manual assessment of individual trajectories in series, which is a time-consuming and
complex task that requires the integration of information across many imaging methods
(figure 7). Optimisation of several parameters for each trajectory is necessary to reach the
target, avoid critical structures, and obtain a suitable entry angle through the skull, and the
different trajectories need to be adjusted to maximise grey matter sampling and avoid
conflicts between electrodes. When placing a new electrode, adjustment of previously
planned trajectories might be needed, making the planning process even more time-
consuming.
Recently, substantial progress has been made in the development of semi-automated

computer-assisted planning software that markedly reduces the planning time by calculating
quantitative measures of trajectory suitability. These measures can be used to select the best
trajectory or to inform manual trajectory selection.103–106 This planning requires the
integration of multimodal imaging data, with each single method being combined together
into a patient-specific three-dimensional map of the brain. The most crucial data are from
CT to show the skull surface, T1-weighted MRI for the grey matter map, and magnetic
resonance angiography, CT angiography, or T1-weighted MRI with gadolinium

enhancement to show the arteries and veins. Different areas of interest indicated by fMRI,
PET, or SPECT imaging can also be added to this three-dimensional map and included in
the planning of different trajectories. Automatic solutions were recently assessed, showing
the potential of these approaches in clinical settings.107
After intracranial electrodes have been placed, seizures can be documented with
simultaneous videoing of the patient and EEG recording from the intracranial electrodes.
Signals from the electrode contacts that record the earliest seizure activity are analysed, as is
the subsequent spread of the activity. The area to be resected is decided after identification
of the epileptogenic zone, taking into account the following: any structural lesion; the
location of eloquent cortex, as inferred from fMRI and precisely located with electrical
stimulation studies; crucial white matter tracts visualised with tractography; the major
arteries and veins; and the location of any previous craniotomy and burr holes. Planning the
surgical approach and the extent of the resection is particularly challenging if the
epileptogenic zone is not located on the convexity of the cerebral hemisphere or if there is no
evident lesion. The use of multimodal three-dimensional imaging to assist this planning has
substantial promise, but one must keep in mind that all imaging and registration has the
potential for some error and does not obviate the need for expert surgical technique.
Future perspectives
Over the next decade, we anticipate increased availability of 7 T clinical MRI scanners with
enhanced sensitivity and improved imaging technology, and development of new magnetic
resonance contrasts and analyses that will improve detection of subtle lesions that underlie
refractory focal epilepsies and that might be amenable to surgical treatment. With the
implementation of uniform protocols for acquisition and processing, we expect that
computerised analysis of the much larger datasets than are acquired at present will become
standard, to achieve data reduction and detection of suspicious areas of focal abnormality for
review by clinicians. Greater sensitivity is likely to be accompanied by reduced specificity;
thus, thorough assessment of the relevance of possible abnormalities will be essential. High-
field MRI of ex-vivo cerebral resection specimens will allow detailed MRI–histological
correlation and has the potential to inform optimisation of MRI sequences for in-vivo use
and identification and prediction of the nature of abnormalities. Integration of several
structural and functional imaging datasets will become routine and will inform clinical
decision making in the presurgical pathway, so that the risk–benefit ratio can be quantified
and optimised for individual patients.
Acknowledgments
JSD has received research grants from the Wellcome Trust (WT106882), the National Institute for Health Research,
and the Medical Research Council (MRC; MR/L013215/1). GPW has received research grants from the MRC (MR/
M00841X/1) and Fight for Sight. MJK has received research grants from the MRC (MR/L013215/1) and the Henry
Smith Charity. SO has received research grants from the Wellcome Trust (WT106882), the Department of Health,
EPSRC (EP/M020533/1, NS/A000027/1, EP/K005278/1, EP/J020990/1), the MRC, the Wolfson Foundation, and
the European Union 7th Framework Programme for Research and Technological Development. The work of all
authors was supported by the National Institute for Health Research University College London Hospitals
Biomedical Research Centre.

References
1. NICE. NICE guideline [CG137]. Epilepsies: diagnosis and managementLondon: National Institute
for Health and Care Excellence; 2012.
2. Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review.
JAMA. 2015; 313:285–93. [PubMed: 25602999]
3. Duncan JS. Imaging and epilepsy. Brain. 1997; 120:339–78. [PubMed: 9117380]
4. Duncan JS. Selecting patients for epilepsy surgery: synthesis of data. Epilepsy Behav. 2011;
20:230–32. [PubMed: 20709601]
5. Téllez-Zenteno JF, Hernández Ronguillo L, Moien-Afshari F, Wiebe S. Surgical outcomes in
lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010;
89:310–18. [PubMed: 20227852]
6. de Tisi J, Bell GS, Peacock JL, et al. The long-term outcome of adult epilepsy surgery, patterns of
seizure remission, and relapse: a cohort study. Lancet. 2011; 378:1388–95. [PubMed: 22000136]
7. Duncan JS. Imaging in the surgical treatment of epilepsy. Nat Rev Neurol. 2010; 6:537–50.
[PubMed: 20842185]
8. Bien CG, Szinay M, Wagner J, Clusmann H, Becker AJ, Urbach H. Characteristics and surgical
outcomes of patients with refractory magnetic resonance imaging-negative epilepsies. Arch Neurol.
2009; 66:1491–99. [PubMed: 20008653]
9. Commission on Neuroimaging of the International League Against Epilepsy. Recommendations for
neuroimaging of patients with epilepsy. Epilepsia. 1997; 38:1255–56. [PubMed: 9579930]
10. Huppertz HJ, Grimm C, Fauser S, et al. Enhanced visualization of blurred gray–white matter
junctions in focal cortical dysplasia by voxel-based 3D MRI analysis. Epilepsy Res. 2005; 67:35–
50. [PubMed: 16171974]
11. Saini J, Kesavadas C, Thomas B, et al. Susceptibility weighted imaging in the diagnostic evaluation
of patients with intractable epilepsy. Epilepsia. 2009; 50:1462–73. [PubMed: 19400870]
12. Wellmer J, Quesada CM, Rothe L, Elger CE, Bien CG, Urbach H. Proposal for a magnetic
resonance imaging protocol for the detection of epileptogenic lesions at early outpatient stages.
Epilepsia. 2013; 54:1977–87. [PubMed: 24117218]
13. Knake S, Triantafyllou C, Wald LL, et al. 3T phased array MRI improves the presurgical
evaluation in focal epilepsies: a prospective study. Neurology. 2005; 65:1026–31. [PubMed:
16217054]
14. Winston GP, Micallef C, Kendell BE, et al. The value of repeat neuroimaging for epilepsy at a
tertiary referral centre: 16 years of experience. Epilepsy Res. 2013; 105:349–55. [PubMed:
23538269]
15. Wisse LE, Biessels GJ, Heringa SM, et al. for the Utrecht Vascular Cognitive Impairment (VCI)
Study Group. Hippocampal subfield volumes at 7T in early Alzheimer’s disease and normal aging.
Neurobiol Aging. 2014; 35:2039–45. [PubMed: 24684788]
16. Coras R, Milesi G, Zucca I, et al. 7T MRI features in control human hippocampus and
hippocampal sclerosis: an ex vivo study with histologic correlations. Epilepsia. 2014; 55:2003–16.
[PubMed: 25366369]
17. Von Oertzen J, Urbach H, Jungbluth S, et al. Standard magnetic resonance imaging is inadequate
for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002; 73:643–47.
[PubMed: 12438463]
18. Huppertz HJ, Kassubek J, Altenmüller DM, Breyer T, Fauser S. Automatic curvilinear reformatting
of three-dimensional MRI data of the cerebral cortex. Neuroimage. 2008; 39:80–86. [PubMed:
17928236]
19. Martin P, Bender B, Focke NK. Post-processing of structural MRI for individualized diagnostics.
Quant Imaging Med Surg. 2015; 5:188–203. [PubMed: 25853079]
20. Farid N, Girard HM, Kemmotsu N, et al. Temporal lobe epilepsy: quantitative MR volumetry in
detection of hippocampal atrophy. Radiology. 2012; 264:542–50. [PubMed: 22723496]
21. Winston GP, Cardoso MJ, Williams EJ, et al. Automated hippocampal segmentation in patients
with epilepsy: available free online. Epilepsia. 2013; 54:2166–73. [PubMed: 24151901]

22. Maccotta L, Moseley ED, Benzinger TL, Hogan RE. Beyond the CA1 subfield: local hippocampal
shape changes in MRI-negative temporal lobe epilepsy. Epilepsia. 2015; 56:780–88. [PubMed:
25809286]
23. Kosior RK, Lauzon ML, Frayne R, Federico P. Single-subject voxel-based relaxometry for clinical
assessment of temporal lobe epilepsy. Epilepsy Res. 2009; 86:23–31. [PubMed: 19464852]
24. Huppertz HJ, Wagner J, Weber B, House P, Urbach H. Automated quantitative FLAIR analysis in
hippocampal sclerosis. Epilepsy Res. 2011; 97:146–56. [PubMed: 21873031]
25. Urbach H, Huppertz HJ, Schwarzwald R, et al. Is the type and extent of hippocampal sclerosis
measurable on high-resolution MRI? Neuroradiology. 2014; 56:731–35. [PubMed: 24973130]
26. Rodionov R, Bartlett PA, He C, et al. T2 mapping outperforms normalised FLAIR in identifying
hippocampal sclerosis. Neuroimage Clin. 2015; 7:788–91. [PubMed: 25844331]
27. Lerner JT, Salamon N, Hauptman JS, et al. Assessment and surgical outcomes for mild type I and
severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia. 2009;
50:1310–35. [PubMed: 19175385]
28. Widdess-Walsh P, Diehl B, Najm I. Neuroimaging of focal cortical dysplasia. J Neuroimaging.
2006; 16:185–96. [PubMed: 16808819]
29. Besson P, Andermann F, Dubeau F, Bernasconi A. Small focal cortical dysplasia lesions are located
at the bottom of a deep sulcus. Brain. 2008; 131:3246–55. [PubMed: 18812443]
30. Rugg-Gunn FJ, Boulby PA, Symms MR, Barker GJ, Duncan JS. Imaging the neocortex in epilepsy
with double inversion recovery imaging. Neuroimage. 2006; 31:39–50. [PubMed: 16460962]
31. Blauwblomme T, Boddaert N, Chémaly N, et al. Arterial spin labeling MRI: a step forward in non-
invasive delineation of focal cortical dysplasia in children. Epilepsy Res. 2014; 108:1932–39.
[PubMed: 25454505]
32. Winston GP, Micallef C, Symms MR, Alexander DC, Duncan JS, Zhang H. Advanced diffusion
imaging sequences could aid assessing patients with focal cortical dysplasia and epilepsy. Epilepsy
Res. 2014; 108:336–39. [PubMed: 24315018]
33. Keller SS, Roberts N. Voxel-based morphometry of temporal lobe epilepsy: an introduction and
review of the literature. Epilepsia. 2008; 49:741–57. [PubMed: 18177358]
34. Colliot O, Bernasconi N, Khalili N, Antel SB, Naessens V, Bernasconi A. Individual voxel-based
analysis of gray matter in focal cortical dysplasia. Neuroimage. 2006; 29:162–71. [PubMed:
16099679]
35. Rugg-Gunn FJ, Boulby PA, Symms MR, Barker GJ, Duncan JS. Whole-brain T2 mapping
demonstrates occult abnormalities in focal epilepsy. Neurology. 2005; 64:318–25. [PubMed:
15668431]
36. Focke NK, Symms MR, Burdett JL, Duncan JS. Voxel-based analysis of whole brain FLAIR at 3T
detects focal cortical dysplasia. Epilepsia. 2008; 49:786–93. [PubMed: 18076641]
37. Focke NK, Bonelli SB, Yogarajah M, Scott C, Symms MR, Duncan JS. Automated normalized
FLAIR imaging in MRI-negative patients with refractory focal epilepsy. Epilepsia. 2009; 50:1484–
90. [PubMed: 19292759]
38. Wagner J, Weber B, Urbach H, Elger CE, Huppertz HJ. Morphometric MRI analysis improves
detection of focal cortical dysplasia type II. Brain. 2011; 134:2844–54. [PubMed: 21893591]
39. Besson P, Bernasconi N, Colliot O, Evans A, Bernasconi A. Surface-based texture and
morphological analysis detects subtle cortical dysplasia. Med Image Comput Comput Assist
Interv. 2008; 11:645–52. [PubMed: 18979801]
40. Ahmed B, Brodley CE, Blackmon KE, et al. Cortical feature analysis and machine learning
improves detection of “MRI-negative” focal cortical dysplasia. Epilepsy Behav. 2015; 48:21–28.
[PubMed: 26037845]
41. Hong SJ, Kim H, Schrader D, Bernasconi N, Bernhardt BC, Bernasconi A. Automated detection of
cortical dysplasia type II in MRI-negative epilepsy. Neurology. 2014; 83:48–55. [PubMed:
24898923]
42. Salmenpera TM, Symms MR, Rugg-Gunn FJ, et al. Evaluation of quantitative magnetic resonance
imaging contrasts in MRI-negative refractory focal epilepsy. Epilepsia. 2007; 48:229–37.
[PubMed: 17295615]

43. Abbott DF, Waites AB, Lillywhite LM, et al. fMRI assessment of language lateralization: an
objective approach. Neuroimage. 2010; 50:1446–55. [PubMed: 20097290]
44. Sanjuan A, Bustamante JC, Forn C, et al. Comparison of two fMRI tasks for the evaluation of the
expressive language function. Neuroradiology. 2010; 52:407–15. [PubMed: 20177671]
45. Wilke M, Schmithorst VJ. A combined bootstrap/histogram analysis approach for computing a
lateralization index from neuroimaging data. Neuroimage. 2006; 33:522–30. [PubMed: 16938470]
46. Berl MM, Zimmaro LA, Khan OI, et al. Characterization of atypical language activation patterns in
focal epilepsy. Ann Neurol. 2014; 75:33–42. [PubMed: 24038442]

47. Jensen EJ, Hargreaves IS, Pexman PM, et al. Abnormalities of lexical and semantic processing in
left temporal lobe epilepsy: an fMRI study. Epilepsia. 2011; 52:2013–21. [PubMed: 21906049]
48. Duke ES, Tesfaye M, Berl MM, et al. The effect of seizure focus on regional language processing
areas. Epilepsia. 2012; 53:1044–50. [PubMed: 22554135]
49. Stewart CC, Swanson SJ, Sabsevitz DS, Rozman ME, Janecek JK, Binder JR. Predictors of
language lateralization in temporal lobe epilepsy. Neuropsychologia. 2014; 60:93–102. [PubMed:
24905283]
50. Labudda K, Mertens M, Janszky J, et al. Atypical language lateralisation associated with right
fronto-temporal grey matter increases—a combined fMRI and VBM study in left-sided mesial
temporal lobe epilepsy patients. Neuroimage. 2012; 59:728–37. [PubMed: 21839176]
51. Janecek JK, Swanson SJ, Sabsevitz DS, et al. Language lateralization by fMRI and Wada testing in
229 patients with epilepsy: rates and predictors of discordance. Epilepsia. 2013; 54:314–22.
[PubMed: 23294162]
52. Benke T, Koylu B, Visani P, et al. Language lateralization in temporal lobe epilepsy: a comparison
between fMRI and the Wada test. Epilepsia. 2006; 47:1308–19. [PubMed: 16922875]
53. Wagner K, Hader C, Metternich B, et al. Who needs a Wada test? Present clinical indications for
amobarbital procedures. J Neurol Neurosurg Psychiatry. 2012; 83:503–09. [PubMed: 22396439]
54. Bonelli SB, Thompson PJ, Yogarajah M, et al. Imaging language networks before and after anterior
temporal lobe resection: results of a longitudinal fMRI study. Epilepsia. 2012; 53:639–50.
[PubMed: 22429073]
55. Rosazza C, Ghielmetti F, Minati L, et al. Preoperative language lateralization in temporal lobe
epilepsy (TLE) predicts peri-ictal, pre- and post-operative language performance: an fMRI study.
Neuroimage Clin. 2013; 3:73–83. [PubMed: 24179851]
56. Mathern GW, Beninsig L, Nehlig A. From the editors: Epilepsia’s survey on the necessity of the
Wada test and intracranial electrodes for cortical mapping. Epilepsia. 2014; 55:1887–89. [PubMed:
25358628]
57. Ille S, Sollmann N, Hauck T, et al. Impairment of preoperative language mapping by lesion
location: a functional magnetic resonance imaging, navigated transcranial magnetic stimulation,
and direct cortical stimulation study. J Neurosurg. 2015; 123:314–24. [PubMed: 25884257]
58. Bonelli SB, Powell RH, Yogarajah M, et al. Imaging memory in temporal lobe epilepsy: predicting
the effects of temporal lobe resection. Brain. 2010; 133:1186–99. [PubMed: 20157009]
59. Alessio A, Pereira FR, Sercheli MS, et al. Brain plasticity for verbal and visual memories in
patients with mesial temporal lobe epilepsy and hippocampal sclerosis: an fMRI study. Hum Brain
Mapp. 2013; 34:186–99. [PubMed: 22038783]
60. Sidhu MK, Stretton J, Winston GP, et al. A functional magnetic resonance imaging study mapping
the episodic memory encoding network in temporal lobe epilepsy. Brain. 2013; 136:1868–88.
[PubMed: 23674488]
61. Binder JR, Sabsevitz DS, Swanson SJ, et al. Use of preoperative functional MRI to predict verbal
memory decline after temporal lobe epilepsy surgery. Epilepsia. 2008; 49:1377–94. [PubMed:
18435753]
62. Towgood K, Barker GJ, Caceres A, et al. Bringing memory fMRI to the clinic: comparison of
seven memory fMRI protocols in temporal lobe epilepsy. Hum Brain Mapp. 2015; 36:1595–608.
[PubMed: 25727386]
63. Sidhu MK, Stretton J, Winston GP, et al. Memory fMRI predicts verbal memory decline after
anterior temporal lobe resection. Neurology. 2015; 84:1512–19. [PubMed: 25770199]

64. Wray CD, Blakely TM, Poliachik SL, et al. Multimodality localization of the sensorimotor cortex
in pediatric patients undergoing epilepsy surgery. J Neurosurg Pediatr. 2012; 10:1–6. [PubMed:
22681317]
65. Woodward KE, Gaxiola-Valdez I, Mainprize D, Grossi M, Goodyear BG, Federico P. Recent
seizure activity alters motor organization in frontal lobe epilepsy as revealed by task-based fMRI.
Epilepsy Res. 2014; 108:1286–98. [PubMed: 25052708]
66. Vitikainen AM, Salli E, Lioumis P, Mäkelä JP, Metsähonkala L. Applicability of nTMS in locating
the motor cortical representation areas in patients with epilepsy. Acta Neurochir (Wien). 2013;
155:507–18. [PubMed: 23328919]
67. Braakman HM, Vaessen MJ, Jansen JF, et al. Frontal lobe connectivity and cognitive impairment in
pediatric frontal lobe epilepsy. Epilepsia. 2013; 54:446–54. [PubMed: 23253092]
68. Voets NL, Menke RA, Jbabdi S, et al. Thalamo-cortical disruption contributes to short-term
memory deficits in patients with medial temporal lobe damage. Cereb Cortex. 2015; 25:4584–95.
[PubMed: 26009613]
69. Yang Z, Choupan J, Reutens D, Hocking J. Lateralization of temporal lobe epilepsy based on
resting-state functional magnetic resonance imaging and machine learning. Front Neurol. 2015;
6:184. [PubMed: 26379618]
70. Morgan VL, Rogers BP, Abou-Khalil B. Segmentation of the thalamus based on BOLD
frequencies affected in temporal lobe epilepsy. Epilepsia. 2015; 56:1819–27. [PubMed: 26360535]
71. Winston GP. Epilepsy surgery, vision, and driving: what has surgery taught us and could modern
imaging reduce the risk of visual deficits? Epilepsia. 2013; 54:1877–88. [PubMed: 24199825]
72. Yogarajah M, Focke NK, Bonelli S, et al. Defining Meyer’s loop-temporal lobe resections, visual
field deficits and diffusion tensor tractography. Brain. 2009; 132:1656–68. [PubMed: 19460796]
73. Piper RJ, Yoong MM, Kandasamy J, Chin RF. Application of diffusion tensor imaging and
tractography of the optic radiation in anterior temporal lobe resection for epilepsy: a systematic
review. Clin Neurol Neurosurg. 2014; 124:59–65. [PubMed: 25016240]
74. Winston GP, Yogarajah M, Symms MR, McEvoy AW, Micallef C, Duncan JS. Diffusion tensor
imaging tractography to visualize the relationship of the optic radiation to epileptogenic lesions
prior to neurosurgery. Epilepsia. 2011; 52:1430–38. [PubMed: 21569018]
75. Winston GP, Daga P, White MJ, et al. Preventing visual field deficits from neurosurgery.
Neurology. 2014; 83:604–11. [PubMed: 25015363]
76. Jeong JW, Asano E, Juhász C, Chugani HT. Quantification of primary motor pathways using
diffusion MRI tractography and its application to predict postoperative motor deficits in children
with focal epilepsy. Hum Brain Mapp. 2014; 35:3216–26. [PubMed: 24142581]
77. Jeong JW, Asano E, Juhász C, Chugani HT. Localization of specific language pathways using
diffusion-weighted imaging tractography for presurgical planning of children with intractable
epilepsy. Epilepsia. 2015; 56:49–57. [PubMed: 25489639]
78. Sommer B, Wimmer C, Coras R, et al. Resection of cerebral gangliogliomas causing drug-resistant
epilepsy: short- and long-term outcomes using intraoperative MRI and neuronavigation. Neurosurg
Focus. 2015; 38:E5.
79. Lilja Y, Nilsson DT. Strengths and limitations of tractography methods to identify the optic
radiation for epilepsy surgery. Quant Imaging Med Surg. 2015; 5:288–99. [PubMed: 25853086]
80. Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS. The utility of 18F-fluorodeoxyglucose PET
(FDG PET) in epilepsy surgery. Epilepsy Res. 2014; 108:1306–14. [PubMed: 25043753]
81. Vinton AB, Carne R, Hicks RJ, et al. The extent of resection of FDG-PET hypometabolism relates
to outcome of temporal lobectomy. Brain. 2007; 130:548–60. [PubMed: 16959818]
82. Koepp MJ, Hammers A, Labbe C, Woermann FG, Brooks DJ, Duncan JS. 11C-flumazenil PET in
patients with refractory temporal lobe epilepsy and normal MRI. Neurology. 2000; 54:332–39.
[PubMed: 10668692]
83. Laufs H, Richardson M, Salek-Haddadi A, et al. Converging PET and fMRI evidence for a
common area involved in human focal epilepsies. Neurology. 2011; 77:904–10. [PubMed:
21849655]

84. Vivash L, Gregoire MC, Lau EW, et al. 18F-flumazenil: a γ-aminobutyric acid A-specific PET
radiotracer for the localization of drug-resistant temporal lobe epilepsy. J Nucl Med. 2013;
54:1270–77. [PubMed: 23857513]
85. Chugani HT, Luat AF, Kumar A, et al. α-[11C]-methyl-L-tryptophan–PET in 191 patients with
tuberous sclerosis complex. Neurology. 2013; 81:674–80. [PubMed: 23851963]
86. Van Paesschen W, Dupont P, Van Driel G, Van Billoen H, Maes A. SPECT perfusion changes
during complex partial seizures in patients with hippocampal sclerosis. Brain. 2003; 126:1103–11.
[PubMed: 12690050]
87. Grouiller F, Thornton RC, Groening K, et al. With or without spikes: localization of focal epileptic
activity by simultaneous electroencephalography and functional magnetic resonance imaging.
Brain. 2011; 134:2867–86. [PubMed: 21752790]
88. van Houdt PJ, De Munck JC, Leijten FS, et al. EEG-fMRI correlation patterns in the presurgical
evaluation of focal epilepsy: a comparison with electrocorticographic data and surgical outcome
measures. Neuroimage. 2013; 75:238–48. [PubMed: 23454472]
89. Thornton R, Vulliemoz S, Rodionov R, et al. Epileptic networks in focal cortical dysplasia revealed
using electroencephalography–functional magnetic resonance imaging. Ann Neurol. 2011;
70:822–37. [PubMed: 22162063]
90. Chaudhary UJ, Carmichael DW, Rodionov R, et al. Mapping preictal and ictal haemodynamic
networks using video-electroencephalography and functional imaging. Brain. 2012; 135:3645–63.
[PubMed: 23250884]
91. Federico P, Abbott DF, Briellmann RS, et al. Functional MRI of the pre-ictal state. Brain. 2005;
128:1811–17. [PubMed: 15975948]
92. Gotman J, Grova C, Bagshaw A, et al. Generalized epileptic discharges show thalamocortical
activation and suspension of the default state of the brain. Proc Natl Acad Sci USA. 2005;
102:15236–40. [PubMed: 16217042]
93. Carmichael DW, Vulliemoz S, Rodionov R, et al. Simultaneous intracranial EEG-fMRI in humans:
protocol considerations and data quality. Neuroimage. 2012; 63:301–09. [PubMed: 22652020]
94. Aghakhani Y, Beers CA, Pittman DJ, Gaxiola-Valdez I, Goodyear BG, Federico P. Co-localization
between the BOLD response and epileptiform discharges recorded by simultaneous intracranial
EEG-fMRI at 3 T. Neuroimage Clin. 2015; 7:755–63. [PubMed: 25844327]
95. Birot G, Spinelli L, Vulliémoz S, et al. Head model and electrical source imaging: a study of 38
epileptic patients. Neuroimage Clin. 2014; 5:77–83. [PubMed: 25003030]
96. Mégevand P, Spinelli L, Genetti M, et al. Electric source imaging of interictal activity accurately
localises the seizure onset zone. J Neurol Neurosurg Psychiatry. 2014; 85:38–43. [PubMed:
23899624]
97. Lascano AM, Perneger T, Vulliemoz S, et al. Yield of MRI, high-density electric source imaging
(HD-ESI), SPECT and PET in epilepsy surgery candidates. Clin Neurophysiol. 2016; 127:150–55.
[PubMed: 26021550]
98. Almubarak S, Alexopoulos A, Von-Podewils F, et al. The correlation of magnetoencephalography
to intracranial EEG in localizing the epileptogenic zone: a study of the surgical resection outcome.
Epilepsy Res. 2014; 108:1581–90. [PubMed: 25241140]
99. Englot DJ, Nagarajan SS, Imber BS, et al. Epileptogenic zone localization using
magnetoencephalography predicts seizure freedom in epilepsy surgery. Epilepsia. 2015; 56:949–
58. [PubMed: 25921215]
100. Aydin Ü, Vorwerk J, Dümpelmann M, et al. Combined EEG/MEG can outperform single
modality EEG or MEG source reconstruction in presurgical epilepsy diagnosis. PLoS One. 2015;
10:e0118753. [PubMed: 25761059]
101. David O, Blauwblomme T, Job AS, et al. Imaging the seizure onset zone with stereoelectro-
encephalography. Brain. 2011; 134:2898–911. [PubMed: 21975587]
102. de Almeida AN, Olivier A, Quesney F, Dubeau F, Savard G, Andermann F. Efficacy of and
morbidity associated with stereoelectroencephalography using computerized tomography- or
magnetic resonance imaging-guided electrode implantation. J Neurosurg. 2006; 104:483–87.
[PubMed: 16619650]

103. Zelmann, R, Beriault, S, Mok, K. , et al. Automatic optimization of depth electrode trajectory
planningClinical image-based procedures. Translational research in medical imaging Lect Notes
Comout SC. Erdt, M, Linguraru, MG, Oyarzun, LC. , et al., editors. Vol. 8361. Springer
International Publishing: 2014. 99–107.
104. Zombori, G, Rodionov, R, Nowell, M. , et al. A computer assisted planning system for the
placement of S-EEG electrodes in the treatment of epilepsyInformation processing in computer-
assisted interventions Lecture Notes in Computer Science. Stoyanov, D, Collins, DL, Sakuma, I,
Abolmaesumi, P, Jannin, P, editors. Vol. 8498. Springer International Publishing; 2014. 118–27.
105. De Momi E, Caborni C, Cardinale F, et al. Automatic trajectory planner for
stereoelectroencephalography procedures: a retrospective study. IEEE Trans Biomed Eng. 2013;
60:986–93. [PubMed: 23221797]
106. De Momi E, Caborni C, Cardinale F, et al. Multi-trajectories automatic planner for
stereoelectroencephalography (SEEG). Int J Comput Assist Radiol Surg. 2014; 6:1087–97.
107. Nowell M, Rodionov R, Zombori G, et al. Comparison of computer-assisted planning and manual
planning for depth electrode implantations in epilepsy. J Neurosurg. 2015; doi:
10.3171/2015.6.JNS15487

Panel 1: Glossary of MRI terms

Arterial spin labelling
An MRI technique that is used to produce quantitative maps of tissue perfusion without
the need for intravenous contrast by magnetically labelling inflowing blood.
Curvilinear reformatting
An alternative approach to traditional cross-sectional display (ie, sagittal, axial, and
coronal) in which the brain is displayed at different depths from the surface, like the
layers of an onion; this method enhances the localisation and detection of dysplastic
lesions.
Diffusion imaging
An MRI technique in which the signal is modulated by the random diffusion of water
molecules; the signal loss in areas of increased diffusion was first used clinically to detect
early ischaemic stroke.
Diffusion tensor imaging

A development of diffusion-weighted imaging in which diffusion is measured in several
directions in each voxel so that the predominant direction of diffusion can be established
and used for tractography; further calculations can be used to derive quantitative tissue
properties.
Diffusional kurtosis imaging

An extension of diffusion-tensor imaging methods that is used to measure both Gaussian
and non-Gaussian distribution of diffusion to provide greater detail about complex tissue
microstructure.
Double-inversion recovery
An MRI sequence with two additional pulses to suppress the signal from both white
matter and CSF, which increases grey–white matter contrast and therefore facilitates the
identification of grey matter lesions.
Fluid-attenuated inversion recovery (FLAIR) imaging

A T2-weighted sequence with an additional pulse to suppress the signal from CSF, which
improves the identification of periventricular lesions.
Intracarotid amobarbital test (Wada test)

A procedure in which one hemisphere is temporarily anaesthetised by intracarotid
injection of sodium amobarbital to measure the laterality of language and memory
functions.
Neurite orientation dispersion and density imaging (NODDI)

An advanced model-based diffusion-weighted imaging method that is used to measure
tissue properties such as intracellular volume fraction and the amount of dispersion of
neurites (ie, axons and dendrites).

Partial volume effects

An artifact that leads to an error in characterisation of tissue type owing to the effects of
averaging signal within a voxel as a result of limited resolution of the imaging system.
Phased-array coil
A type of MRI coil that receives signal to produce an image from several coils rather than
a single coil to improve signal-to-noise ratio and facilitate faster imaging.
Region-of-interest-based approach
A type of analysis applied to MRI data in which a specific region (eg, the hippocampus)
is delineated manually or automatically to measure a property of that region.
Surface-based morphometry
An approach to the study of brain shape and size (morphometry) that is used to
investigate features of the brain surface such as cortical thickness and curvature.
Susceptibility-weighted imaging
A newer MRI technique than T2*-gradient echo imaging that is sensitive to the effects of
paramagnetic and diamagnetic compounds such as blood products and calcium; this
method improves the identification of lesions such as cavernomas.
T1-weighted imaging
One of the basic MRI sequences that produces images in which contrast predominantly
depends on the T1 relaxation times of the tissues; this weighting is typically used to
emphasise anatomical structure.
T2 relaxometry
A quantitative MRI technique used to measure T2 relaxation, in contrast to methods that

produce images qualitatively affected by T2 relaxation (T2-weighted imaging); the
resulting maps are helpful for the identification of hippocampal sclerosis.
T2-weighted imaging
One of the basic MRI sequences that produces images in which contrast predominantly
depends on the T2 relaxation times of the tissues; this weighting is typically used to
emphasise pathological abnormalities.
T2*-gradient echo imaging

A commonly used clinical MRI sequence that produces images sensitive to iron-
containing compounds such as blood products; this method is helpful for the
identification of vascular malformations and microbleeds.
Tractography
A non-invasive method to delineate white matter connections from diffusion-weighted
imaging data; one approach is to trace the predominant direction of diffusion from
diffusion-tensor imaging data.

Volumetry
The technique of measuring the volume of a structure, either manually or automatically;
this method is useful for measuring hippocampal volumes to detect hippocampal atrophy.
Voxel-based morphometry
A statistical approach to the study of brain shape and size (morphometry) that enables
comparisons of brain imaging data from groups of people or from an individual with
reference to template images, to identify where focal changes occur in properties such as
grey matter volume.

Panel 2: MRI acquisition protocol for the identification of structural

abnormalities in patients with epilepsy
Three-dimensional volumetric T1-weighted imaging (1 mm isotropic voxels)
This method provides excellent grey–white matter contrast and allows the assessment of
cortical thickness and detection of malformations of cortical development. Images can be

reformatted into any plane and post-processing techniques can be used to improve
detection of abnormalities.
T2-weighted imaging (axial and coronal)

This imaging method allows assessment of hippocampal architecture and cystic tissue
components of other lesions. The two orthogonal planes allow small lesions to be
distinguished from partial volume effects, which are minimised by acquiring images
orthogonal to the long axis of the hippocampus.
Fluid-attenuated inversion recovery imaging (axial and coronal)

This imaging method is sensitive to hippocampal sclerosis, focal cortical dysplasia,
tumours, inflammation, and scars.
T2* gradient echo or susceptibility-weighted imaging (axial)

This method is sensitive to calcified and vascular lesions, such as cavernomas and
arteriovenous malformations.11

Search strategy and selection criteria

We searched PubMed for English language articles published between Jan 1, 2005, and
Nov 1, 2015, with the search terms “epilep*” and one or more of “MRI”, “fMRI”,
“functional MRI”, “PET”, “SPECT”, “MEG”, “electric* source imaging”, “EEG”,
“DTI”, “diffusion MRI”, and “surgery”. We also included key earlier references from the
authors’ files. We selected reports for inclusion in this paper that we judged to be most
relevant to clinical practice.

Figure 1. The pathways of assessment for epilepsy surgery, showing the place of brain imaging
18F-FDG=18F-fluorodeoxyglucose.
EEG=electroencephalography.
MEG=magnetoencephalography. Adapted from Duncan,4 by permission of Elsevier.

Figure 2. MRI acquisition protocols for the identification of structural cerebral abnormalities in
epilepsy
Focal cortical dysplasia with cortical thickening and a blurred grey–white matter junction
(circled) on (A) T1-weighted imaging and (B) with high signal intensity on T2-weighted
FLAIR imaging. Right hippocampal sclerosis with volume loss (circled) on (C) T1-weighted
imaging, (D) with high signal intensity on T2-weighted FLAIR imaging, and (E) with loss
of internal architecture on T2-weighted PROPELLER imaging. (F) A cavernoma in the left
inferior temporal gyrus (circled) can be seen clearly as an area of signal dropout on T2*-
weighted images. (G) Application of a voxel-based image post-processing method to T1-

weighted three-dimensional MRI data from a 38-year-old woman enabled enhanced

visualisation of focal cortical dysplasia on the resulting junction image (blurred grey–white
matter junction) and extension image (grey matter extending abnormally into white matter).
The corresponding slice is shown on the original T1-weighted image. (A–F) were acquired
on a 3 T scanner with (A, C) a three-dimensional fast spoiled gradient echo T1-weighted
sequence (0.9375 × 0.9375 mm in-plane resolution, 1·1 mm slice thickness), (B) an axial
and (D) an oblique coronal T2-weighted FLAIR sequence (0·9375 × 0·9375 mm in-plane
resolution, 5 mm slice thickness), (E) a coronal oblique T2-weighted PROPELLER
sequence (0·43 × 0·43mm in-plane resolution, 2 mm slice thickness), and (F) a coronal fast
gradient recalled echo T2*-weighted sequence (0·9375 × 0·9375 mm in-plane resolution, 5
mm slice thickness). For all images, left side of image=right side of brain.
FLAIR=fluid-attenuated inversion recovery. PROPELLER=periodically rotated overlapping
parallel lines with enhanced reconstruction. Panel G adapted from Huppertz and colleagues,
10 by permission of Elsevier.

Figure 3. Neurite orientation dispersion and density imaging for the detection of focal cortical
dysplasia
A 27-year-old male with focal cortical dysplasia in the left inferior temporal gyrus. The area
(circled) is defined poorly on structural images including volumetric T1-weighted (A) and
T2-weighted coronal oblique (B) images and on standard diffusion images including
fractional anisotropy (C) and mean diffusivity (D) maps. Focal cortical dysplasia is easily
visible as a reduced intracellular volume fraction on neurite orientation dispersion and
density imaging, an advanced diffusion MRI sequence (E). Reproduced from Winston and
colleagues.32

Figure 4. Functional MRI for prediction of changes in verbal memory after temporal lobe
surgery
(A) Correlations between functional MRI activation in response to words remembered and
postoperative verbal memory decline in patients with left TLE (n=23) and right TLE (n=27).
In patients with both left TLE and right TLE, the surface-rendered whole-brain images
(upper panel) show that left frontal activations were significantly correlated with greater
postoperative verbal memory decline. No correlation was found in the right hemisphere in
patients with left or right TLE. The sliced images (lower panel) show that predominantly left
medial temporal lobe activations were significantly correlated with greater postoperative

verbal memory decline in patients with left TLE. A similar correlation was not found for
patients with right TLE. (B) Correlation of individual lateralisation indices for words
remembered in the frontotemporal region (using an anatomical mask) in patients with left
TLE (n=23) with change in list learning 4 months after left anterior temporal lobe resection
(R2=0·43). Each circle represents one patient. The vertical red line shows the level of
significant decline calculated by the reliable change index using control data. The horizontal
dashed line shows a lateralisation index of 0·5 (left>right), with scores of ≥0·5 indicative of
strong left lateralisation. Seven of eight patients who experienced a significant verbal
memory decline had a lateralisation index of at least 0·5, which was the strongest predictor
of postoperative verbal memory decline. TLE=temporal lobe epilepsy. Reproduced from
Sidhu and colleagues,63 by permission of Wolters Kluwer Health.

Figure 5. Optic radiation tractography for surgical guidance

(A) Optic radiation tractography data can be superimposed on the coronal fluid-attenuated
inversion recovery MRI scan to show the relation with a cavernoma to aid surgical planning
and (B) can also be displayed in three-dimensional renderings. Panels A and B reproduced
from Winston and colleagues,74 by permission of John Wiley & Sons. (C) Tractography data
can then be displayed on the operating microscope display in real time for surgical guidance.
Panel C adapted from Winston and colleagues,75 by permission of Wolters Kluwer Health.

Figure 6. 18F-fluorodeoxyglucose PET imaging for the localisation of epileptogenic brain regions
in MRI-negative focal epilepsy
18F-fluorodeoxyglucose PET scan showing left temporal hypometabolism in a 32-year-old
man with normal MRI and left temporal lobe epilepsy (A, axial slice; B, coronal slice). (C)
Results of a statistical voxel-based comparison of surface-rendered glucose uptake in the
patient, compared with a set of control data (using Neurostat-3D SSP software). An area of
hypometabolism (green) is evident in the left temporal lobe (right panel). The patient
became seizure free after left temporal lobe resection. Reproduced from Rathore and
colleagues,80 by permission of Elsevier.

Figure 7. Integration of multimodal three-dimensional imaging in the epilepsy surgery pathway

Stereo-EEG implantation plan. Each electrode is depicted in a separate colour. All images
are taken from the left posteriolateral direction. (A) Veins (blue) extracted from gadolinium-
enhanced T1-weighted MRI and arteries (red) extracted from CT angiogram. (B) A lesion
identified from T2-weighted FLAIR MRI (purple) and motor (green) and language (orange)
regions identified from functional MRI. (C) The lesion and motor and language regions in

(B) are shown on a volume-rendered T1-weighted MRI. FLAIR=fluid-attenuated inversion

recovery.

bjr-83-493 Tir

Uploaded by

Copyright:

Available Formats

bjr-83-493 Tir

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

bjr-83-493 Tir

Uploaded by

Copyright:

Available Formats

Europe PMC Funders Group

Brain imaging in the assessment for epilepsy surgery

Gavin P Winston, PhD,

Prof Matthias J Koepp, PhD,

Prof Sebastien Ourselin, PhD

Brain imaging is of fundamental importance to diagnosis and treatment of epilepsy,

In the interpretation of imaging studies, an important factor is recognition of the difference

The sequence of presurgical imaging investigations

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Identification of structural cerebral abnormalities

Additional sequences, in particular fluid-attenuated inversion recovery (FLAIR) MRI, have

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

subsequently at 3 T showed relevant new diagnoses in 37 (5%), in particular hippocampal

Assessment of structural data

Hippocampal sclerosis—Hippocampal sclerosis is the most common cause of surgically

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Focal cortical dysplasia—Cortical malformations, in particular focal cortical dysplasia,

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Data interpretation for advanced imaging methods

Mapping eloquent brain functions

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

In individuals with left temporal lobe epilepsy, predominantly left-sided anterior

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Resting state and connectivity

Mapping cerebral white matter connections

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Delineation of the corticospinal tract in patients undergoing frontal lobe surgery is

Localisation of epileptic activity

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

nanomolar range. This versatility depends on the availability of a cyclotron and

α-11C-methyl-L-tryptophan was considered originally to be a marker of serotonin synthesis,

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

EEG-fMRI, ESI, and MSI

for planning intracranial implantations,88 with widespread abnormalities taken as a warning

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Integration of multimodal three-dimensional imaging in the epilepsy

Recently, substantial progress has been made in the development of semi-automated

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

focal epilepsy. Ann Neurol. 2014; 75:33–42. [PubMed: 24038442]

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Panel 1: Glossary of MRI terms

Diffusion tensor imaging

Diffusional kurtosis imaging

Fluid-attenuated inversion recovery (FLAIR) imaging

Intracarotid amobarbital test (Wada test)

Neurite orientation dispersion and density imaging (NODDI)

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.

Partial volume effects

a single coil to improve signal-to-noise ratio and facilitate faster imaging.

A quantitative MRI technique used to measure T2 relaxation, in contrast to methods that

T2*-gradient echo imaging

Lancet Neurol. Author manuscript; available in PMC 2019 September 10.